Form D · Biotechnology

Biostax Corp.

Winter Park, FL · CIK 0001559356

Offering snapshot reported Jun 8, 2026 · SEC filing

Reported sold
$0
Offering amount: $7.45M
Investors reported
20
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Dec 22, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 8, 2026Initial$0No comparison20SEC filing
Aug 31, 2022InitialYet to sellNo comparison0SEC filing
Aug 2, 2022Initial$400,000No comparison1SEC filing
Apr 2, 2015Initial$200,000No comparison1SEC filing
Sep 25, 2013Amendment$2,892,750$2,692,750vs Oct 2, 201235SEC filing
Nov 15, 2012Amendment$200,000$0vs Oct 2, 20122SEC filing
Oct 2, 2012Initial$200,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-586575

Source: Form D, filed Jun 8, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Peter Aronstam Executive
Vincent Butta Director
Angus Dalgleish Executive
Cynthia Douglas Executive
Seth Elliott Executive
Glen Farmer Executive
Joseph Fortunak Executive
Noreen Griffin Executive
Gloria Herndon Director
Roscoe Moore Director
Christopher Pearce Director
Kevin Phelps Director
Nicholas Plotnikoff Director
Clifford Selsky Director
Fengpin Shan Director, Executive
Fengping Shan Executive
Edward Teraskiewicz Director
Stephen Wilson Director, Executive
Robert Wilson Director
Kelly Wilson Executive
Eugene Youkilis Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2431 Aloma Ave, Suite 124
Winter Park, FL, 32792